POLR3G and cancer: In fact, pan-cancer comparison of survival signatures across all cancer subtypes reveals that POLR3G expression is the most significant feature and predictor of poor survival outcomes compared with all other Pol III subunits (Figure 2A) (Smith and Sheltzer, 2022).